All In MedTech

Device Trial Radar · NCT04289051

Clinical Evaluation of Oral Rinse for Xerostomia

Clinical Evaluation of the Efficacy of an Intra Oral Rinse for Patients With Xerostomia

Last checked: Nov 20, 2026Latest source record: Feb 24, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

39

Actual

Start

Aug 19, 2020

Primary completion

Feb 4, 2021

Study completion Feb 4, 2021

Sponsor

Lead sponsor
Sunstar AmericasNot on our public-company list
Sponsor type
Industry
First posted
Feb 28, 2020

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Crossover
Masking
Double (participant, outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Xerostomia causes a difficulty in eating, have irritated oral tissues, and a poor quality of life. The new oral rinse was designed to reduce the symptoms and improve the patient's quality of life. The objectives of the clinical study is to evaluate the effectiveness of the oral rinse comparing to the placebo product and the control product in the market. This is a randomized double-blind placebo controlled crossover study with 39 patients receiving treatment. Patients will be randomly allocated to three treatment groups. Patients will use the assigned oral rinse four times a day for two weeks. Dry mouth symptoms and other endpoints will be assessed subjectively and objectively at baseline and Day 14. Patients will be assigned to another treatment after one week wash-out period.

Conditions

  • Xerostomia

Interventions

  • HYDRAL Oral RinseDevice

    Application 4 times a day for two weeks

  • BIOTENE® Oral RinseDevice

    Application 4 times a day for two weeks

  • Placebo Oral RinseDevice

    Application 4 times a day for two weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in Dry Mouth Symptom by Visual Analog Scale at 14 Days From BaselineTime frame: Baseline, 14 days
  2. Change in Dry Mouth Symptoms by Xerostomia Questionnaire at 14 Days From BaselineTime frame: Baseline, 14 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University at Buffalo, The Center for Dental Studies

    Buffalo, New York

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.